This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Alexion Pharmaceuticals Inc (ALXN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 529.86M 989.50M 540.86M 267.14M
Receivables 421.75M 295.60M 244.29M 168.73M
Inventories 102.60M 94.52M 81.39M 62.16M
Other Current Assets 18.93M 14.62M 4.75M 7.50M
Total Current Assets 2.19B 1.50B 941.27M 646.56M
Property, Plant & Equipment, Gross 305.21M 245.62M 226.46M 205.29M
Accumulated Depreciation & Depletion 104.10M 79.99M 60.61M 43.05M
Property, Plant & Equipment, Net 201.11M 165.63M 165.85M 162.24M
Intangibles 609.72M 646.68M 91.60M 24.15M
Other Non-Current Assets 62.54M 38.05M 12.52M 4.57M
Total Non-Current Assets 1.13B 1.12B 453.48M 365.48M
Liabilities & Shareholder Equity
Total Assets 3.32B 2.61B 1.39B 1.01B
Accounts Payable 145.89M 109.27M 37.78M 16.03M
Short Term Debt 48.00M 48.00M 727.00K 715.00K
Other Current Liabilities 228.84M 121.60M 50.78M 11.85M
Total Current Liabilities 582.43M 360.09M 230.22M 138.52M
Long Term Debt 65.00M 101.00M 0.00 3.72M
Deferred Income Taxes 101.24M 19.83M 0.00 0.00
Other Non-Current Liabilities 154.72M 161.79M 29.85M 9.32M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 353.19M 282.62M 30.03M 13.79M
Total Liabilities 935.62M 642.71M 260.26M 152.30M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 2.38B 1.97B 1.13B 859.74M
Common Par 20.00K 20.00K 19.00K 6.00K
Additional Paid In Capital 2.11B 1.85B 1.26B 1.17B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 379.10M 126.20M -128.62M -303.93M
Treasury Stock -80.36M -14.23M -2.68M -2.68M
Other Equity Adjustments -22.86M 6.64M 4.18M -7.14M
Total Capitalization 2.45B 2.07B 1.13B 863.45M
Total Equity 2.38B 1.97B 1.13B 859.74M
Total Liabilities & Stock Equity 3.32B 2.61B 1.39B 1.01B
Total Common Shares Outstanding 196.96M 194.69M 185.52M 182.99M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 985.00K 227.00K 97.00K 388.00K
Basic Weighted Shares Outstanding 195.53M 190.46M 183.22M 178.54M
Diluted Weighted Shares Outstanding 199.71M 198.50M 191.81M 186.07M
Number of Employees 1774 1373 1008 792
Number of Part-Time Employees 0 0 0 0
ALXN News

ALXN Alexion Pharmaceuticals Inc

Analysts Ratings for ALXN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 12 11 11
Moderate Buy 1 1 1 1
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ALXN ANALYST REPORT

Brokerage Partners

ALXN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs